Altimmune, Inc. (ALT)
NASDAQ: ALT · IEX Real-Time Price · USD
6.28
-0.27 (-4.12%)
At close: Jul 19, 2024, 4:00 PM
6.37
+0.09 (1.43%)
Pre-market: Jul 22, 2024, 7:33 AM EDT
Altimmune Market Cap
Altimmune has a market cap or net worth of $445.27 million as of July 22, 2024. Its market cap has increased by 168.88% in one year.
Market Cap
445.27M
Enterprise Value
263.20M
1-Year Change
168.88%
Ranking
Category
Stock Price
$6.28
Market Cap Chart
Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $445.27M, an increase of 446.34%. That is a compound annual growth rate of 9.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 445.30M | -26.32% |
| Dec 29, 2023 | 604.40M | -25.26% |
| Dec 30, 2022 | 808.70M | 122.17% |
| Dec 31, 2021 | 364.00M | -2.41% |
| Dec 31, 2020 | 373.00M | 1,186.21% |
| Dec 31, 2019 | 29.00M | 61.11% |
| Dec 31, 2018 | 18.00M | -42.12% |
| Dec 29, 2017 | 31.10M | -85.66% |
| Dec 30, 2016 | 216.90M | 77.06% |
| Dec 31, 2015 | 122.50M | 6.80% |
| Dec 31, 2014 | 114.70M | 17.88% |
| Dec 31, 2013 | 97.30M | 79.52% |
| Dec 31, 2012 | 54.20M | -11.58% |
| Dec 30, 2011 | 61.30M | -64.57% |
| Dec 31, 2010 | 173.00M | 210.59% |
| Dec 31, 2009 | 55.70M | -6.39% |
| Dec 31, 2008 | 59.50M | -31.77% |
| Dec 31, 2007 | 87.20M | 1.04% |
| Dec 29, 2006 | 86.30M | 4.10% |
| Dec 30, 2005 | 82.90M | 1.72% |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioventus | 459.56M |
| Voyager Therapeutics | 455.82M |
| Nkarta | 454.52M |
| Absci | 454.03M |
| Pacific Biosciences of California | 450.75M |
| Nano-X Imaging | 444.12M |
| Aura Biosciences | 434.74M |
| Ocugen | 433.64M |